| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Clinical Science and Laboratory Medicine [N. H., S. I., K. S., R. K.], and The Second Division of the Department of Internal Medicine [N. H., Y. F., H. I.], Kyoto University, School of Medicine, Shogoin Kawaharacho 54, Sakyo-ku, Kyoto 606, and The Second Division of the Department of Biochemistry, Teikyo University, School of Medicine, Tokyo 173 [N. I., I. I.], Japan
Two murine monoclonal antibodies, 2H6G5 (IgM) and 4A9E10 (IgG3), were obtained by using either cultured human hepatocellular carcinoma cells (PLC/PRF/5) or the acidic glycolipid mixture prepared from the same cells as immunogens. The antigen in PLC/PRF/5 cell membranes recognized by both antibodies was identified as a disulfated acidic glycolipid, GgOse4Cer-II3IV3-bis-sulfate (SB1a). Both antibodies reacted specifically with SB1a, and no significant reactivity was noted with other sulfated glycolipids or gangliosides except that the antibody 2H6G5 showed a weak cross-reactivity with LacCer-II3-sulfate (SM3), another sulfated glycolipid which partly shares the same carbohydrate structure as SB1a. The SB1a antigen is a relatively minor glycolipid in PLC/PRF/5 cells, but it was strongly expressed at the surface of PLC/PRF/5 cells as ascertained by cytofluorometry using both antibodies. A significant amount of SB1a antigen was present in 3 of the acidic glycolipid fractions isolated from 15 human hepatocellular carcinoma tissues as well as in the acidic glycolipid fraction prepared from PLC/PRF/5 cells, while all the acidic glycolipid fractions prepared from cirrhotic livers and a normal liver were essentially negative for SB1a, as ascertained by both solid phase enzyme immunoassay and the thin-layer chromatography-immunostaining method. These results strongly suggest that the SB1a antigen as defined by these new monoclonal antibodies is associated with human hepatocellular carcinoma.
1 This work was supported in part by a grant-in-aid for Cancer Research from the Ministry of Education, Science and Culture, Japan, and grants-in-aid from the Japanese Foundation for Multidisciplinary Treatment of Cancer, the Uehara Memorial Foundation, and the Princess Takamatsu Cancer Research Foundation, to R. K.
2 To whom requests for reprints should be addressed.
Received 4/19/88. Revised 8/ 5/88. Accepted 8/11/88.
This article has been cited by other articles:
![]() |
M. Kyogashima, K. Tamiya-Koizumi, T. Ehara, G. Li, R. Hu, A. Hara, T. Aoyama, and R. Kannagi Rapid demonstration of diversity of sulfatide molecular species from biological materials by MALDI-TOF MS Glycobiology, August 1, 2006; 16(8): 719 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ideo, A. Seko, and K. Yamashita Galectin-4 Binds to Sulfated Glycosphingolipids and Carcinoembryonic Antigen in Patches on the Cell Surface of Human Colon Adenocarcinoma Cells J. Biol. Chem., February 11, 2005; 280(6): 4730 - 4737. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |